Log In
Print
BCIQ
Print
Print this Print this
 

NAV4694 (formerly AZD4694)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionFluorine-18 (F-18) labeled PET imaging agent that binds beta amyloid
Molecular Target Beta amyloid
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase III
Standard IndicationNeurology, Diagnostic
Indication DetailsDetect beta amyloid plaque deposition in the brain to aid diagnosis of Alzheimer's disease (AD); Detect cerebral beta amyloid in end-of-life subjects with and without dementia; Predict progression to Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI)
Regulatory Designation

Partner

Navidea Biopharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today